Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Investigating the Biological Efficacy of Albumin-Enriched Platelet-Rich Fibrin (Alb-PRF): A Study on Cytokine Dynamics and Osteoblast Behavior.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Lourenço, Emanuelle Stellet1 (AUTHOR) ; Rocha, Neilane Rodrigues Santiago1,2 (AUTHOR) ; de Lima Barbosa, Renata1,2 (AUTHOR) ; Mello-Machado, Rafael Coutinho1 (AUTHOR) ; de Souza Lima, Victor Hugo1,2 (AUTHOR) ; Leite, Paulo Emilio Correa2 (AUTHOR); Pereira, Mariana Rodrigues2 (AUTHOR); Casado, Priscila Ladeira3 (AUTHOR) ; Kawase, Tomoyuki4 (AUTHOR) ; Mourão, Carlos Fernando5 (AUTHOR) ; Alves, Gutemberg Gomes1,2 (AUTHOR)
- Source:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11531. 18p.
- Subject Terms:
- Additional Information
- Abstract:
The development of effective biomaterials for tissue regeneration has led to the exploration of blood derivatives such as leucocyte- and platelet-rich fibrin (L-PRF). A novel variant, Albumin-Enriched Platelet-Rich Fibrin (Alb-PRF), has been introduced to improve structural stability and bioactivity, making it a promising candidate for bone regeneration. This study aimed to evaluate Alb-PRF's capacity for cytokine and growth factor release, along with its effects on the proliferation, differentiation, and mineralization of human osteoblasts in vitro. Alb-PRF membranes were analyzed using histological, scanning electron microscopy, and fluorescence microscopy techniques. Cytokine and growth factor release was quantified over seven days, and osteoinductive potential was evaluated with MG-63 osteoblast-like cells. Structural analysis showed Alb-PRF as a biphasic, highly cellularized material that releases lower levels of inflammatory cytokines and higher concentrations of platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) compared to L-PRF. Alb-PRF exhibited higher early alkaline phosphatase activity and in vitro mineralization (p < 0.05) and significantly increased the OPG/RANKL mRNA ratio (p < 0.05). These results indicate that Alb-PRF has promising potential as a scaffold for bone repair, warranting further in vivo and clinical assessments to confirm its suitability for clinical applications. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.